$89.69 2%
LMAT Stock Price vs. AI Score
Data gathered: October 17

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About LeMaitre Vascular

LeMaitre Vascular Inc provides medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons.


LeMaitre Vascular
Price $89.69
Target Price Sign up
Volume 60,450
Market Cap $2.05B
Year Range $58.59 - $92.93
Dividend Yield 0.69%
PE Ratio 54.63
Analyst Rating 71% buy
Earnings Date October 31 '24
Industry Medical & Dental Instruments

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q2 '24112M39M38M12M16M0.520
Q1 '24107M39M37M9.9M13M0.440
Q4 '2349M43M33M8.5M12M0.380
Q3 '2347M36M31M7.5M11M0.330
Q2 '23100M37M32M8.1M11M0.360

Insider Transactions View All

Roberts David B filed to sell 14,114 shares at $82.1.
August 15 '24
Kamke Trent G filed to sell 4,561 shares at $81.8.
August 7 '24
LeMaitre George W filed to sell 1,900,956 shares at $86.7.
July 18 '24
LeMaitre George W filed to sell 1,958,328 shares at $86.3.
July 16 '24
LeMaitre George W filed to sell 1,985,358 shares at $86.1.
July 16 '24

What is the Market Cap of LeMaitre Vascular?

The Market Cap of LeMaitre Vascular is $2.05B.

What is LeMaitre Vascular's PE Ratio?

As of today, LeMaitre Vascular's PE (Price to Earnings) ratio is 54.63.

When does LeMaitre Vascular report earnings?

LeMaitre Vascular will report its next earnings on October 31 '24.

What is the current stock price of LeMaitre Vascular?

Currently, the price of one share of LeMaitre Vascular stock is $89.69.

How can I analyze the LMAT stock price chart for investment decisions?

The LMAT stock price chart above provides a comprehensive visual representation of LeMaitre Vascular's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling LeMaitre Vascular shares. Our platform offers an up-to-date LMAT stock price chart, along with technical data analysis and alternative data insights.

Does LMAT offer dividends to its shareholders?

Yes, LeMaitre Vascular (LMAT) offers dividends to its shareholders, with a dividend yield of 0.69%. This dividend yield represents LeMaitre Vascular's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering LeMaitre Vascular in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of LeMaitre Vascular?

Some of the similar stocks of LeMaitre Vascular are Align Technology, Dentsply, iRhythm Technologies, NovoCure, and Silk Road Medical.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.